Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast Cancer
Status:
Completed
Trial end date:
2017-10-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate anti-cancer stem cell (CSC) activity (measured by
the amount of Aldehyde dehydrogenase 1/ALDH1+ cells before and after treatment) of
pre-operative bevacizumab in combination with conventional chemotherapy in breast cancer
receiving neo-adjuvant treatment, compared to a control arm receiving chemotherapy alone.